Apolipoprotein B (ApoB) is the primary protein component of LDL and other atherogenic lipoproteins. Elevated blood glucose (hyperglycemia) drives hepatic VLDL overproduction via insulin resistance, increasing ApoB particle number. Additionally, glucose can glycate ApoB, making LDL more susceptible to oxidation and atherogenesis. The relationship is well established: type 2 diabetes and metabolic syndrome are associated with higher ApoB levels, independent of LDL cholesterol. ApoB is considered a more accurate cardiovascular risk marker than LDL-C. Improving glycemic control through diet, exercise, or medication can lower ApoB. Caveat: The provided context lacks direct studies on ApoB and blood sugar; this answer relies on general medical consensus. Evidence grade: human-moderate (observational and interventional studies, but not from the given context).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-e3a220411fde516a306efa6a